Komori
Share Issuance and Disposal4586Medrx Co.,Ltd.Pharmaceuticals

Notice Regarding the Large-Scale Exercise of the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued Through a Third-Party Allotment

From 16 to 17 July 2026, 1,699,900 shares underlying the 35th Stock Acquisition Rights were exercised, reducing the number of unexercised rights from 98,496 to 81,497.

Worth reading
60In focus
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
1699900
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Large-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)

発行・処分する株式数

1,699,900 new shares (65,500 shares on 16 July and 1,634,400 shares on 17 July)

Intended allottee
グロース・キャピタル株式会社 (allottee of the already issued stock acquisition rights)
Terms of the stock acquisition rights
Exercise price
¥50 on 16 July and ¥50 on 17 July. Details of the adjustment clause and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 147,820 rights; exercised since the previous disclosure: 16,999 rights; currently unexercised: 81,497 rights
Most recent equity financing
Issued on 5 June 2026: the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment, with 147,820 rights issued in total
Details of issuance or disposal
ItemDetails
Type of issuance or disposalLarge-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Number of shares to be issued or disposed of1,699,900 new shares (65,500 shares on 16 July and 1,634,400 shares on 17 July)
Intended allotteeグロース・キャピタル株式会社 (allottee of the already issued stock acquisition rights)
Exercise price¥50 on 16 July and ¥50 on 17 July. Details of the adjustment clause and the adjustment floor: Not disclosed
Number of Stock Acquisition RightsTotal issued: 147,820 rights; exercised since the previous disclosure: 16,999 rights; currently unexercised: 81,497 rights
Most recent equity financingIssued on 5 June 2026: the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment, with 147,820 rights issued in total
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This disclosure was made because a large-scale exercise occurred. No specific reason for the large-scale exercise was provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Large-Scale Exercise of the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued Through a Third-Party Allotment | Medrx Co.,Ltd. (4586) timely disclosure | Komori